Department of Thoracic Surgery, Konya Education and Research Hospital, Konya, Turkey.
Eur J Cardiothorac Surg. 2012 Jan;41(1):10-3. doi: 10.1016/j.ejcts.2011.03.056.
In the present prospective double-blind randomized trial, the effects of intermittent paravertebral subpleural bupivacaine and morphine on pain management in patients undergoing thoracotomy were evaluated and compared with intermittent systemic analgesia.
Forty-five patients undergoing elective lobectomy were included in the present study. Three randomized groups consisting of 15 patients each were compared. Those in the control group were administered intravenously with tramadol 100 mg plus metamizol 1000 mg every 4 h for 3 days. We placed the catheter just below the parietal pleura along the paravertebral sulcus at the level of T5-T7. At the end of the operation and every 4 h thereafter, the patients received either 1.5 mg kg(-1) bupivacaine (bupivacaine group) or 0.2 mg kg(-1) morphine sulfate (morphine group) with paravertebral subpleural catheter for 3 days. Data regarding demographics, visual analog pain scores, need for supplementary intravenous analgesia, pulmonary function tests, and postoperative pulmonary complications were recorded for each patient.
Visual analog pain scores (visual analog scale (VAS)) were lower in the morphine and bupivacaine groups compared with control group at all postoperative time points. The mean postoperative VAS was significantly different between the control and bupivacaine groups at postoperative hour 12, the control and morphine groups at postoperative hours 6, 12, 48, and 72, and the bupivacaine and morphine groups at postoperative hours 6 and 24 (p<0.05). In the control group, additional analgesic requirement was significantly higher than in the bupivacaine and morphine groups (p<0.05). Postoperative pulmonary complications occurred in three patients (20%) in the control group, in two patients (13%) in the bupivacaine group, and in one (6%) in the morphine group.
The patients undergoing lung resection through a thoracotomy were observed with reduced postoperative pain and better surgical outcomes with respect to the length of hospital stay, postoperative forced expiratory volume in the first second, pulmonary complications, and need for bronchoscopic management, when paravertebral subpleural analgesia was induced by morphine.
在本前瞻性双盲随机试验中,评估并比较了肋间胸膜下布比卡因和吗啡间断给药在开胸术后患者疼痛管理中的作用,与间断全身镇痛进行比较。
本研究纳入 45 例行择期肺叶切除术的患者。将他们分为三组,每组 15 例,进行随机比较。对照组患者静脉给予曲马多 100mg 加甲灭酸 1000mg,每 4 小时 1 次,共 3 天。我们将导管置于肋胸膜下沿着 T5-T7 水平的肋间沟。手术结束时,此后每 4 小时,患者接受肋间胸膜下导管注射 1.5mg/kg 布比卡因(布比卡因组)或 0.2mg/kg 硫酸吗啡(吗啡组),共 3 天。记录每位患者的人口统计学数据、视觉模拟疼痛评分、补充静脉镇痛需求、肺功能检查和术后肺部并发症。
与对照组相比,吗啡组和布比卡因组在所有术后时间点的视觉模拟疼痛评分(VAS)均较低。对照组和布比卡因组在术后 12 小时,对照组和吗啡组在术后 6、12、48 和 72 小时,布比卡因组和吗啡组在术后 6 和 24 小时的平均术后 VAS 有显著差异(p<0.05)。对照组的额外镇痛需求明显高于布比卡因组和吗啡组(p<0.05)。对照组有 3 例(20%)、布比卡因组有 2 例(13%)、吗啡组有 1 例(6%)患者发生术后肺部并发症。
与对照组相比,接受开胸肺切除术的患者术后疼痛减轻,住院时间、术后第 1 秒用力呼气量、肺部并发症和支气管镜管理需求等手术结局更好,当肋间胸膜下使用吗啡进行镇痛时。